TeleDocs360 review

What it is

TeleDocs360 (TELEDOCS360 LLC, 5865 Ridgeway Center Pkwy, Memphis, Tennessee) is a cash-pay telehealth platform providing administrative and support services, with medical care stated as delivered by licensed physicians affiliated with Impact Health, an independent physician network, and medication compounded and dispensed by a licensed US pharmacy. Its published weight-management menu is compounded semaglutide at $299/mo, compounded tirzepatide at $399/mo and phentermine at $149/mo, each stated as one flat monthly price covering doctor, medication and shipping. Its NAD⁺ line is sold as an "Energy & Focus Add-On" on a page not linked from any menu.

How it works

Asynchronous and quiz-led. You book a package, complete a secure medical intake described as ten to fifteen minutes, a licensed provider reviews it and confirms whether the selected treatment is appropriate, and medication ships to your door with a refill and messaging flow through a patient portal. The NAD⁺ page states two formulation choices — a 500 mg injectable vial described as the high-potency option, or a needle-free nasal spray for daily use — with the provider guiding usage. It also carries a supplement-style FDA disclaimer beneath the formulation choice, which sits oddly next to a page describing a prescription workflow, and is worth noticing. Two gaps matter more than the page layout. No compounding pharmacy is named, only "a licensed US pharmacy". And no state availability list is published anywhere, so eligibility is discovered during intake rather than before it, which is the friction point on a site that otherwise moves quickly. The company does publish a street address and a phone number, which is more corporate identity than a good share of this board offers.

Pricing transparency

The NAD⁺ figure is clean in structure and modest in specificity: "as low as $139 a month", with the page stating that the program includes physician-guided approval, the NAD⁺ formulation for your chosen route, supplies for at-home use, shipping and portal access — in its own words, "no separate visits, hidden fees, or additional steps". That is an all-in monthly number, which is what this board rewards, and it is the figure we publish. What it does not tell you is how much NAD⁺ you get per month: the injectable is described as 500 mg per vial, but the number of vials in a month, the dosing frequency and the nasal spray strength are all absent, and the page notes that higher doses require more medication and can raise your monthly cost. So treat $139 as an entry rate for a starting dose, not as a settled monthly bill. Everything else priced on the site — semaglutide at $299, tirzepatide at $399, phentermine at $149 — is a weight-loss figure and none of it should be read as an NAD⁺ price. There is also a standalone $69 consultation advertised elsewhere on the site that explicitly does not include medication; that is a separate product, not this one.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The site's own disclaimer states that medications are compounded and dispensed by a licensed US pharmacy following a provider consultation, but names no facility, and compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, this is a program whose marketing claims — sustained energy, sharper focus, reduced fatigue — run well ahead of anything the data supports. Injected NAD⁺ has no controlled human outcome trials; the single human intravenous study was a pharmacokinetic pilot showing infused NAD⁺ clears plasma quickly. Intranasal NAD⁺ has less support again, with no controlled outcome data and thin pharmacokinetics. The NAD⁺ forms with human trial data are the oral precursors nicotinamide riboside and nicotinamide mononucleotide, and what those trials reliably show is a raised blood NAD⁺ level — a biomarker, not a demonstrated clinical benefit. Individual results vary.

Pros and watch-outs

The evidence behind what TeleDocs360 prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• NAD injections: how to get them near you or online, and what the evidence really says

  Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.

• NAD⁺ nasal spray: the delivery format with the least direct evidence

  Intranasal NAD⁺ is convenient and heavily marketed — but no controlled human trial shows the spray raises systemic or brain NAD⁺. A straight comparison with the better-studied routes.

How TeleDocs360 compares

A few alternatives worth a look, depending on what you’re optimizing for.

• TETelePeptide

  NAD⁺ buyers who want the month-to-month rate published beside the prepay rates

  See TelePeptide →
• TWTyde Wellness

  NAD⁺ buyers who want five named pharmacies, a published state list and the route stated with the price

  See Tyde Wellness →
• THTrava Health

  Buyers who want six named pharmacies and will confirm the NAD⁺ figure against the product page, not the tile

  See Trava Health →